论文部分内容阅读
目前的产业政策和产业环境更有利于大型医药流通企业的发展。而且我们认为,购并、重组、联合仍是未来医药流通行业发展的亮点,随着行业并购的加速,市场集中度将进一步提升,企业规模效益也将逐步显现。
The current industrial policies and industrial environment are more conducive to the development of large pharmaceutical distribution enterprises. And we think mergers and acquisitions, reorganizations and joint ventures are still the bright spots in the future development of the pharmaceutical circulation industry. With the acceleration of industry mergers and acquisitions, market concentration will be further enhanced and the scale of enterprises will gradually show its benefits.